z-logo
Premium
Enumeration andCharacterization of Human Killer and Natural Killer Cells by a Modified Single‐Cell Assay
Author(s) -
WÅHLIN B.,
ALSHEIKHLY A.,
PERLMANN P.,
SCHREIBER R. D.,
MÜLLEREBERHARD H. J.
Publication year - 1984
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1111/j.1365-3083.1984.tb00964.x
Subject(s) - cytotoxic t cell , mastocytoma , lymphokine activated killer cell , biology , cytotoxicity , effector , natural killer cell , natural killer t cell , microbiology and biotechnology , interleukin 21 , interleukin 12 , cell , in vitro , immunology , biochemistry
Human natural killer (NK) and killer (K) cells were assayed in a modified single‐cell cytotoxicity assay using poly‐L‐lysine‐coated cover slips. When human Chang liver cells were used as targets, 20% of the lymphocytes formed conjugates and 2% were active NK cells. When anti‐Chang antibodies were present, the proportion of target‐binding cells (TBC) increased to 30% and that of the cytotoxic effector cells (comprising NK + K) to 6%. With the mouse mastocytoma cells (P815), which are not susceptible to NK, similar proportions of lymphocytes formed conjugates, and 6–9% were active as K cells. By an in situ rosetting assay a significant fraction of the TBC and cytotoxic effector cells bound either C3b or C3bi in both systems, with a certain predominance of C3bi‐binding cells among the K cells. However, by indirect immunofluorescence, significantly more OKT3 + cells than OKM1 + cells were TBC or cytotoxic in the Chang cell system, whereas the OKT3 + /OKM1 + ratios for both TBC and cytotoxic cells were 1:1 in the mouse mastocytoma system. The results indicate that TBC, NK and K cells are heterogeneous with respect to surface marker expression and that effector cells of different phenotypes predominate in different target systems.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here